DERM - CIK 0001867066
Journey Medical Corp (DERM) reported revenue of $61.86M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $61.86M | +10.2% |
| FY 2024 | $56.13M | -29.1% |
| FY 2023 | $79.18M | +7.5% |
| FY 2022 | $73.67M | +16.7% |
| FY 2021 | $63.13M | +41.8% |
| FY 2020 | $44.53M | - |
Journey Medical Corp (DERM) reported revenue of $61.86M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Journey Medical Corp's revenue grew from $44.53M to $61.86M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.